Severe Progressive Autism Associated with Two de novo Changes: A 2.6-Mb 2q31.1 Deletion and a Balanced t(14;21)(q21.1;p11.2) Translocation with Long-Range Epigenetic Silencing of LRFN5 Expression.

Molecular Syndromology
D R H de BruijnG Houge

Abstract

In a 19-year-old severely autistic and mentally retarded girl, a balanced de novo t(14;21)(q21.1;p11.2) translocation was found in addition to a de novo 2.6-Mb 2q31.1 deletion containing 15 protein-encoding genes. To investigate if the translocation might contribute to developmental stagnation at the age of 2 years with later regression of skills, i.e. a more severe phenotype than expected from the 2q31.1 deletion, the epigenetic status and expression of genes proximal and distal to the 14q21.1 breakpoint were investigated in Ebstein Barr Virus-transformed lymphoblast and primary skin fibroblast cells. The 14q21.1 breakpoint was found to be located between a cluster of 7 genes 0.1 Mb upstream, starting with FBXO33, and the single and isolated LRFN5 gene 2.1 Mb downstream. Only expression of LRFN5 appeared to be affected by its novel genomic context. In patient fibroblasts, LRFN5 expression was 10-fold reduced compared to LRFN5 expressed in control fibroblasts. In addition, a relative increase in trimethylated histone H3 lysine 9 (H3K9M3)-associated DNA starting exactly at the translocation breakpoint and going 2.5 Mb beyond the LRFN5 gene was found. At the LRFN5 promoter, there was a distinct peak of trimethylated histone H3 ly...Continue Reading

References

Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·H KawasakiA M Graybiel
Apr 3, 2001·Nature Reviews. Genetics·T Cremer, C Cremer
Feb 21, 2002·The Journal of Clinical Investigation·Heiko KrudeAnnette Grüters
Aug 17, 2002·Science·Hai YanKenneth W Kinzler
Apr 2, 2003·Nature Genetics·Stéphane JamainUNKNOWN Paris Autism Research International Sibpair Study
Jul 3, 2004·The Journal of Clinical Investigation·Hana RaslovaRémi Favier
Jul 23, 2004·Current Biology : CB·Craig L Peterson, Marc-André Laniel
Nov 19, 2004·American Journal of Human Genetics·Dirk A Kleinjan, Veronica van Heyningen
May 11, 2006·Proceedings of the National Academy of Sciences of the United States of America·Daniel MertensPeter Lichter
Sep 12, 2006·Genome Research·Christoph GrunauAlbertina De Sario
Oct 5, 2006·Cancer Research·Diederik R H de BruijnAd Geurts van Kessel
Nov 24, 2006·Nature·Richard RedonMatthew E Hurles
Feb 27, 2007·Cell·Tony Kouzarides
May 2, 2007·Journal of Neuroscience Research·Jaewon Ko, Eunjoon Kim
Jun 2, 2007·Science·David S JohnsonBarbara Wold
Nov 16, 2007·Pflügers Archiv : European journal of physiology·Nael Nadif Kasri, Linda Van Aelst
Mar 29, 2008·American Journal of Human Genetics·Julia BaptistaJohn A Crolla
Aug 8, 2008·Nucleic Acids Research·Raja JothiKeji Zhao
Nov 7, 2008·PloS One·Reuben SabaStephanie A Booth

❮ Previous
Next ❯

Citations

Jan 30, 2013·The Journal of Cell Biology·Katherine L PettemAnn Marie Craig
Dec 15, 2015·Expert Review of Neurotherapeutics·Glaucia Chiyoko Akutagava-MartinsMara Helena Hutz
Jul 9, 2011·Seminars in Cell & Developmental Biology·Jungyong NamEunjoon Kim
May 14, 2011·American Journal of Medical Genetics. Part a·Emmanouil ManolakosMichael B Petersen
Jan 15, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ting WangYing Chen
Oct 22, 2015·European Journal of Human Genetics : EJHG·Julien ThevenonLaurence Faivre
Oct 7, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cristina Sánchez-MoraMarta Ribasés
Jun 4, 2019·European Journal of Human Genetics : EJHG·Gerarda CappuccioNicola Brunetti-Pierri
Aug 12, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Amanda M Buch, Conor Liston
Apr 21, 2018·Frontiers in Molecular Neuroscience·Eunkyung LieEunjoon Kim
Jan 20, 2018·Nature Communications·Zhaohan LinHeli Liu
Dec 17, 2011·The Journal of Biological Chemistry·Gail K SeaboldRobert J Wenthold

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.